Hepatitis C virus inhibitors are disclosed having the general formula: ##STR1##

    • wherein R1, R2, R3, R, B, Y and X are described in the description.

      Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.

    •  
    Web www.patentalert.com

    < Utilization of interferon alpha 5 in the treatment of viral hepatopathies

    < Cyclic undecapeptide pro-drugs and uses thereof

    > Packaging of positive-strand RNA virus replicon particles

    > Methods of inactivating viruses
    ~ 00237